NYSE - Nasdaq Real Time Price USD

Encompass Health Corporation (EHC)

Compare
92.41 -0.24 (-0.26%)
As of 10:52 AM EDT. Market Open.
Loading Chart for EHC
DELL
  • Previous Close 92.65
  • Open 93.06
  • Bid 92.00 x 800
  • Ask 92.18 x 900
  • Day's Range 91.84 - 93.59
  • 52 Week Range 57.55 - 94.59
  • Volume 94,060
  • Avg. Volume 636,460
  • Market Cap (intraday) 9.299B
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) 22.87
  • EPS (TTM) 4.04
  • Earnings Date Oct 24, 2024 - Oct 28, 2024
  • Forward Dividend & Yield 0.68 (0.73%)
  • Ex-Dividend Date Oct 1, 2024
  • 1y Target Est 100.91

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

www.encompasshealth.com

27,253

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EHC

View More

Performance Overview: EHC

Trailing total returns as of 9/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EHC
39.02%
S&P 500
19.91%

1-Year Return

EHC
32.39%
S&P 500
32.39%

3-Year Return

EHC
57.00%
S&P 500
30.12%

5-Year Return

EHC
93.74%
S&P 500
91.15%

Compare To: EHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EHC

View More

Valuation Measures

Annual
As of 9/20/2024
  • Market Cap

    9.32B

  • Enterprise Value

    12.11B

  • Trailing P/E

    22.93

  • Forward P/E

    20.20

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.86

  • Price/Book (mrq)

    5.07

  • Enterprise Value/Revenue

    2.39

  • Enterprise Value/EBITDA

    11.06

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.88%

  • Return on Assets (ttm)

    8.09%

  • Return on Equity (ttm)

    23.11%

  • Revenue (ttm)

    5.07B

  • Net Income Avi to Common (ttm)

    409M

  • Diluted EPS (ttm)

    4.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    154.4M

  • Total Debt/Equity (mrq)

    116.41%

  • Levered Free Cash Flow (ttm)

    42.06M

Research Analysis: EHC

View More

Company Insights: EHC

Research Reports: EHC

View More

People Also Watch